未登录

H

Haifeng Luo

Hengjiu Special Materials Co., Ltd.

H指数:18

被引数:1,307

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

The development of high thermal conductivity die steel with excellent performance: Integrating alloy design, heat treatment, and ceramic particle reinforcement

高性能高导热性模具钢的开发：整合合金设计、热处理和陶瓷颗粒增强

Journal of Materials Research and Technology

IF6.6

2025-11-250

OAAI

Multiscale orchestration of microstructures in duplex stainless steel via introduction of trace nanoceramics

通过引入微量纳米陶瓷实现双相不锈钢微观结构的多尺度协同调控

Materials Science and Engineering: A

IF0

2025-10-170

PRE

Endoscopic treatment of unresectable perihilar cholangiocarcinoma: beyond biliary drainage

不可切除性肝门部胆管癌的内镜治疗：超越胆道引流

THERAPEUTIC ADVANCES IN GASTROENTEROLOGY

IF3.4

2025-04-140

OA

Potential value of novel multiparametric MRI radiomics for preoperative prediction of microsatellite instability and Ki-67 expression in endometrial cancer

SCIENTIFIC REPORTS

IF3.9

2025-01-251

OAAI

One-Stage Intraoperative ERCP combined with Laparoscopic Cholecystectomy Versus Two-Stage Preoperative ERCP Followed by Laparoscopic Cholecystectomy in the Management of Gallbladder with Common Bile Duct Stones: A Meta-analysis

ADVANCES IN THERAPY

IF4

2024-08-291

PRE

Bruceine A alleviates alcoholic liver disease by inhibiting AIM2 inflammasome activation via activating FXR

IF8.3

2024-07-014

PRE

FXR overexpression prevents hepatic steatosis through inhibiting AIM2 inflammasome activation in alcoholic liver disease

HEPATOLOGY INTERNATIONAL

IF6.1

2024-01-064

PRE

Efficacy and complications of inoperable malignant distal biliary obstruction treatment by metallic stents: fully covered or uncovered?

GASTROENTEROLOGY REPORT

IF4.2

2023-08-223

OAAI

RETRACTION: Integrin-β5, a miR-185-targeted gene, promotes hepatocellular carcinoma tumorigenesis by regulating β-catenin stability (Retraction of Vol 37, art no 17, 2018)

JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH

IF12.8

2023-07-190

OAAI

ORM 1 as a biomarker of increased vascular invasion and decreased sorafenib sensitivity in hepatocellular carcinoma

BOSNIAN JOURNAL OF BASIC MEDICAL SCIENCES

IF3.4

2022-10-2311

OAAI

Neoadjuvant Therapy for Pancreatic Ductal Adenocarcinoma: Where Do We Go?

FRONTIERS IN ONCOLOGY

IF3.3

2022-06-164

OAAI

USP22 regulates lipidome accumulation by stabilizing PPARγ in hepatocellular carcinoma

NATURE COMMUNICATIONS

IF15.7

2022-04-2187

OAAI

Activation of PGC-1α via isoliquiritigenin-induced downregulation of miR-138-5p alleviates nonalcoholic fatty liver disease

通过异甘草素诱导的miR-138-5p下调激活PGC-1α 减轻非酒精性脂肪性肝病

PHYTOTHERAPY RESEARCH

IF6.3

2022-01-1813

PRE

Yangonin modulates lipid homeostasis, ameliorates cholestasis and cellular senescence in alcoholic liver disease via activating nuclear receptor FXR

IF8.3

2021-09-0124

PREAI

Luteolin ameliorates LPS-induced acute liver injury by inhibiting TXNIP-NLRP3 inflammasome in mice

IF8.3

2021-07-0176

PREAI

PRAS40 hyperexpression promotes hepatocarcinogenesis (vol 51, 102604, 2020)

IF10.8

2020-10-010

OAAI

PRAS40 hyperexpression promotes hepatocarcinogenesis

IF10.8

2020-01-0115

OAAI

USP10 suppresses tumor progression by inhibiting mTOR activation in hepatocellular carcinoma

IF10.1

2018-11-0158

PREAI

RETRACTED: Integrin-β5, a miR-185-targeted gene, promotes hepatocellular carcinoma tumorigenesis by regulating β-catenin stability (Retracted article. See vol. 42, 2023)

JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH

IF12.8

2018-01-3145

OAAI

Osthole inhibits the tumorigenesis of hepatocellular carcinoma cells

ONCOLOGY REPORTS

IF3.9

2017-01-2434

OAAI